e-learning
resources
ERS Research Seminars
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New drugs for severe asthma – what should we target and how?
K.F. Chung (London, United Kingdom)
Source:
Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Number:
6
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K.F. Chung (London, United Kingdom). New drugs for severe asthma – what should we target and how?. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
How common is stepping-down asthma treatment in England?
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017
Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005
Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021
Do we need new therapies for noneosinophilic asthma?
Source: Annual Congress 2004 - Noneosinophilic asthma
Year: 2004
New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012
What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021
Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007
New mechanisms and targets in COPD
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014
New guidelines for chronic cough: what’s in and what’s out
Source: International Congress 2019 – New clinical practice guidelines for chronic cough
Year: 2019
Update on severe asthma: what we know and what we need
Source: Eur Respir Rev 2009; 18: 58-65
Year: 2009
Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019
Potential drugs to treat smokers with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
New perspectives of basic aspirin-induced asthma therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept